HMVSX
Price
$18.06
Change
+$0.01 (+0.06%)
Updated
Sep 5 closing price
Net Assets
1.16B
JVMCX
Price
$28.15
Change
+$0.02 (+0.07%)
Updated
Sep 5 closing price
Net Assets
24.32B
Interact to see
Advertisement

HMVSX vs JVMCX

Header iconHMVSX vs JVMCX Comparison
Open Charts HMVSX vs JVMCXBanner chart's image
Hartford MidCap Value R4
Price$18.06
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.16B
JHancock Disciplined Value Mid Cap C
Price$28.15
Change+$0.02 (+0.07%)
VolumeN/A
Net Assets24.32B
HMVSX vs JVMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMVSX vs. JVMCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVSX is a Buy and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.3B vs. HMVSX (1.16B). HMVSX pays higher dividends than JVMCX: HMVSX (0.48) vs JVMCX (0.00). HMVSX was incepted earlier than JVMCX: HMVSX (15 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than HMVSX (1.18). HMVSX is a more actively managed with annual turnover of: 132.00 vs. JVMCX (49.00). HMVSX has a lower initial minimum investment than JVMCX: HMVSX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : 1.22 vs. HMVSX (-4.73). JVMCX return over 5 years is better than : 48.03 vs. HMVSX (34.74).
HMVSXJVMCXHMVSX / JVMCX
Total Expense Ratio1.181.8564%
Annual Report Gross Expense Ratio1.181.8663%
Fund Existence15 years14 years-
Gain YTD3.37711.26530%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B24.3B5%
Annual Yield % from dividends0.480.00-
Returns for 1 year-4.731.22-387%
Returns for 3 years5.9221.2528%
Returns for 5 years34.7448.0372%
Returns for 10 years18.7145.0542%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALSSF2.960.06
+2.07%
Alsea SA
ACBD0.60N/A
N/A
Annabidiol Corp.
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
TIAOF0.53N/A
N/A
Telecom Italia S.p.A.
INPAP80.00N/A
N/A
International Paper Company